If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
JOURNALS | ||
![]() HIV Medicine© 2010 British HIV Association Journal Home | Journal Information | Society | News | Most Cited Product Information | Editorial Board | For Authors | Advertise | Contact | Online Submission Current IssueVolume 11 Issue 3 (March 2010)Original ResearchCD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients (p 161-169) Abstract
|
References | Full Text:
HTML,
PDF (Size: 209K)
Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study (p 170-177) Abstract
|
References | Full Text:
HTML,
PDF (Size: 677K)
Risk factors for HIV transmission among heterosexual discordant couples in South India* (p 178-186) Abstract
|
References | Full Text:
HTML,
PDF (Size: 102K)
Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects (p 187-192) Abstract
|
References | Full Text:
HTML,
PDF (Size: 97K)
Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers (p 193-199) Abstract
|
References | Full Text:
HTML,
PDF (Size: 131K)
Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir (p 200-208) Abstract
|
References | Full Text:
HTML,
PDF (Size: 378K)
Trends in uptake of recently approved antiretrovirals within a national healthcare system (p 209-215) Abstract
|
References | Full Text:
HTML,
PDF (Size: 118K)
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression (p 216-224) Abstract
|
References | Full Text:
HTML,
PDF (Size: 171K)
|